Connect with us

BUSINESS

FSSAI Ties Nestlé Formula Claims to an Instagram Reel

India’s food regulator put Nestlé, Abbott and influencer Ira Fathima on one infant-formula file.

Published

on

India’s food regulator named Nestlé India, Abbott Healthcare and three other parties on 21 October 2026 over an Instagram reel that ranked infant formula. The Food Safety and Standards Authority of India also asked Nestlé to prove pack lines on Lactogen Pro 1 Powder and NAN Excella Pro Stage 1, labels already sitting in three adjudication cases opened on 18 September.

The reel’s creator, Ira Fathima, is on the same notice as the brands. Abbott says it never hired her and learned of the video only after the regulator wrote.

Nestlé’s Same Pack Claims Were Already in Court

FSSAI’s 21 October post looked like a new infant-formula case. For Nestlé’s two packs, it was a public restatement of a file the authority had already taken to adjudication on 18 September, when it said it had opened three separate cases under the Food Safety and Standards Act, 2006.

Two of those cases concern promotional lines on NAN Excella Pro Stage 1 and Lactogen Pro 1, including “5 HMOs helps support the normal immune system” and whey protein described as easy to digest. The third is a laboratory finding: a Nestlé follow-up formula sample was classed sub-standard for biotin, and a referral lab reached the same result.

On 18 September FSSAI wrote that it had looked at the two infant products and at promotional material on e-commerce sites, then found the claims in breach of Regulation 4(2) of the 2020 infant nutrition labelling rules, which bars pictures, graphics and phrases designed to increase the saleability of infant milk substitutes or infant food. It also cited Section 3 of the Infant Milk Substitutes Act, 1992, which prohibits advertising and promotion of the products the Act covers.

The 21 October NAN notice went a step further on the immune line. FSSAI said the wording could imply the product is suitable for supporting the immune system in relation to a particular body condition, and treated that as a breach of rules on disease and condition claims that bar prevention, alleviation, treatment or cure language unless a specific regulation allows it. Nestlé was told to explain why action should not follow under the 2006 Act.

THE FILE FROM SEPTEMBER TO OCTOBER

  1. 18 September 2026: FSSAI says it has filed three adjudication cases against Nestlé India over NAN Excella Pro Stage 1, Lactogen Pro 1 and a follow-up formula sample that failed biotin tests twice.
  2. 17 October 2026: The regulator issues separate notices on Nestlé Resource Renal vanilla powder and Hindustan Unilever Horlicks lines, and proposes cutting sucrose and fructose in foods for infants up to six months.
  3. 21 October 2026: FSSAI restates the Lactogen and NAN pack questions, adds a five-party Instagram notice, and questions Complan growth claims from Zydus Wellness Products.

The gap from the September cases to the October restatement is 33 days. Nestlé’s public line did not change with the calendar.

The Reel That Put Four Brands on One Notice

The new piece of the 21 October file is not another tin. It is a ranking video. FSSAI said an Instagram reel posted by Ira Fathima, who uses the handle @ira_fathima, ran a “Top 5” list of infant formula and tied the products to balanced nutrition, stronger immunity, brain development and easy digestion.

The authority named four manufacturers and the creator on one notice, and asked all five to explain why it should not proceed under the 2006 Act. It said the reel appeared to breach the Infant Milk Substitutes Act, 1992, as amended in 2003, and the 2020 infant-nutrition rules on advertising, marketing and promotion.

PRODUCTS NAMED IN THE REEL

Product in the reel Company on the FSSAI notice
Nan-Pro 1 Nestlé India
Aptamil Premium 1 Nutricia International
Similac Advance 1 Abbott Healthcare
Enfamil A+ Stage 1 Mead Johnson Nutrition (India), owned by Reckitt Benckiser
Dexolac 1 Nutricia International

Nan-Pro 1 in that list is not the NAN Excella Pro Stage 1 pack already in the September cases. Nestlé is on both files for different products: a labelled claim on one SKU, and a third-party ranking that named another.

Abbott’s reply is the sharpest corporate split. The company said it had no relationship with the creator, was not involved in the post, and saw the video only after the notice arrived. “The content was independently created and published by a third party without Abbott’s knowledge, involvement or authorisation,” it said, and added that it does not endorse the lines in the reel.

FSSAI still put Abbott on the paper. That is the move the pack-claim story hides. A brand that never bought the post is being asked to show cause because the post used its product name and assigned it health benefits the law does not allow anyone to advertise.

What the 1992 Ban Does to Unpaid Posts

India does not run a light-touch code for formula marketing. Parliament passed the 1992 infant milk substitutes law to regulate production, supply and distribution of infant milk substitutes, feeding bottles and infant foods, with the stated aim of protecting breastfeeding. The Act came into force on 1 August 1993 and was tightened in 2003.

Section 3 is written in a way that does not care who paid the invoice. “No person shall advertise, or take part in the publication of any advertisement,” it says, for the distribution, sale or supply of infant milk substitutes, feeding bottles or infant foods. A second clause bars any person from taking part in the promotion of those products. The Act’s definition of advertisement already includes electronic transmission and audio or visual transmission, which is the legal path from a 1990s statute to an Instagram reel.

The 2020 infant-nutrition regulations fold that statute into food-safety law. They require infant foods to comply with Sections 3, 4, 5, 7, 8, 9 and 10 of the 1992 Act on advertising, marketing and promotion, and they add their own pack rules. Every container must carry “IMPORTANT NOTICE” and the line “MOTHER’S MILK IS BEST FOR YOUR BABY” in capital letters at least five millimetres high, on the front of the pack, in a colour that stands off the background. The same rules ban infant or woman pictures on the pack and bar phrases such as “Health Food” or “Complete Food.”

A ranking reel that assigns immunity and brain development to five tins sits a long way from that mandated warning. The legal question FSSAI has now put on paper is whether the person who posted it, and the companies whose products were named, each “took part” in a promotion the Act forbids.

WHAT SECTION 3 AND THE PACK RULES FORBID

  • Paid or unpaid ads: Section 3(a) bars any person from advertising infant milk substitutes, feeding bottles or infant foods, or taking part in publishing such an advertisement.
  • Promotion by any method: Section 3(c) bars any person from taking part in promotion of those products, and the Act defines promotion as any method, direct or indirect, of encouraging purchase or use.
  • Saleability on the pack: Regulation 4(2) of the 2020 rules bars pictures of infants or women and any graphic or phrase designed to increase saleability, including “humanised” or “maternalised.”
  • Disease and condition lines: Advertising rules separately bar claims about prevention, alleviation, treatment or cure of a disease, disorder or particular physiological condition unless another regulation allows the wording.

The 1992 Act’s own money penalty for an advertising breach is small. Section 20(1) sets imprisonment for a term that may extend to three years, or a fine that may extend to Rs 5,000, or both. That fine is not a figure that moves a listed multinational. FSSAI is not relying on it alone. The 21 October letters ask the parties to show cause under the 2006 food-safety statute, which is the administrative track the authority already used for the three September Nestlé cases.

Nestlé Says the Labels Already Had a Stamp

Nestlé India’s defence on the pack file is that the regulator is arguing with wording an FSSAI expert committee already allowed. After the 18 September cases, a company spokesperson said the products and their labels had been approved by that committee, and that the statements on the label were factual and backed by scientific literature.

Our products are fully compliant with all the applicable regulations. The said products (i.e., NAN EXCELLA PRO & LACTOGEN PRO) and their labels were approved by the expert committee of FSSAI. In response to the notice, we have again submitted our detailed response to the authorities regarding statements appearing on the label, which are factual in nature, and supported by scientific literature.

Nestlé India spokesperson, 18 September 2026 statement

On 21 October the company treated the new social post as a repeat. “FSSAI’s recent post reiterates the points raised in its earlier post of 18 September regarding product labels. We have already submitted our detailed response to FSSAI on these matters,” a spokesperson said. On 23 October it said the same thing again about the Lactogen whey line: the detailed response was already in.

That leaves two live disputes on one company. On the tins, Nestlé says the science is in and the committee signed the art. On the reel, it has not published a separate public defence of Nan-Pro 1’s appearance in Fathima’s list. Abbott has drawn a brighter line, and the line still did not keep it off the notice.

WHAT WE KNOW

  • The notices: FSSAI has issued show-cause letters on the Lactogen and NAN pack claims, on the five-party Instagram reel, and on Complan advertising, and it already filed three Nestlé adjudication cases on 18 September.
  • The replies: Nestlé says the pack labels were committee-approved and that it has filed a detailed response; Abbott says it did not create, pay for or endorse the reel.

WHAT IS UNCONFIRMED

  • Who paid: FSSAI has not published evidence that any of the four manufacturers commissioned or approved Fathima’s video.
  • What follows: It is not yet public whether the September adjudication and the October letters will be heard as one Nestlé file, or whether Fathima faces a separate proceeding under the 1992 Act.

If the brands truly had no contract, the 1992 drafting still helps the regulator more than it helps them, because the banned actor is “any person,” not “any advertiser of record.” The cost of that reading is obvious to every company that sells Stage 1 powder: a stranger’s ranking video can arrive as a show-cause letter.

Complan, Horlicks and a Kidney Powder

The 21 October infant-formula notices sat inside a wider FSSAI run at health language on packs and ads. The same day, the authority questioned Zydus Wellness Products over Complan, including “2X Faster Growth,” “Supports Concentration and Memory,” and “Pro Immunity+ 34 Vital Nutrients.” It asked for scientific justification of lines that Complan is “clinically proven” to help children grow taller faster, and it flagged the slogan “Growth Comes in 4 Flavors” as offside advertising rules. Complan is a growing-up drink, not an infant milk substitute, so that file runs on claims law rather than the 1992 advertising ban.

COMPLAN LINES FSSAI FLAGGED

  • Growth speed: “2X Faster Growth” and “grow taller, faster, clinically proven 2X growth,” for which the regulator wants the underlying trials.
  • Mind and immunity: “Supports Concentration and Memory” and “Pro Immunity+ 34 Vital Nutrients,” grouped with other child-health claims the notice treats as unsubstantiated.
  • Flavour slogan: “Growth Comes in 4 Flavors,” cited as a non-compliant advertising line rather than a nutrient claim.

Four days earlier, on 17 October, FSSAI had already posted notices to Nestlé India and Hindustan Unilever. Nestlé’s Resource Renal vanilla powder, sold for the dietary management of conservatively treated chronic kidney disease, was treated as a food for special medical purpose that needed prior approval the company had not obtained, and the pack was also flagged for a missing vegetarian or non-vegetarian symbol. Horlicks Women’s Plus Chocolate was questioned on bone-strength claims, a “Healthy Muscles” line, a “No Added Sugar” claim on a product that contains maltodextrin, and a “100% RDA of Calcium, Vitamin D & K2” statement. Horlicks Mother’s Plus Kesar was questioned on “Healthy Birth Weight” and on e-commerce wording that folded pregnancy, birth weight and DHA into the product name.

The same 17 October window brought a draft amendment to restrict sucrose and fructose in foods for infants up to six months, which FSSAI said was aimed at cutting early exposure to added sugars. In August, the authority said it had issued more than 150 notices to food companies in recent months over misleading ads, false claims and labelling, a sweep that already included Nestlé India.

Taken together, the infant-formula letters are not a one-off spat about whey. They are the baby-food edge of a claims audit that has reached coffee drinks, kidney powder, malted beverages and now a mother-influencer’s ranking list.

BPNI Flagged Mother Bloggers Years Before This Reel

The Breastfeeding Promotion Network of India has been the statutory watchdog on this beat since a gazette notification of 27 July 1995 authorised it to start action under Section 21(1) of the IMS Act. Its 2022-23 baby food law offenders report logged 15 violations between June 2022 and May 2023 and said the count was “just a tip of the iceberg.”

That report is where the Instagram problem stops being a surprise. BPNI wrote that “new tactics of involving celebrities, influencers mothers, mother bloggers on Instagram and YouTube is certainly catching on,” and that those posters, “knowingly or unknowingly,” were infringing the law and liable to be penalised. It also quoted the 1992 Statement of Objects and Reasons, which told Parliament that promotion of infant milk substitutes “do constitute a health hazard” and had been “more extensive and pervasive” than information on the advantages of mother’s milk.

The same document set the commercial scale against India’s feeding numbers. It cited a 2022 WHO figure putting the formula milk industry at more than US$55 billion, and NFHS-5 (2019-21) rates of 41.8% for initiation of breastfeeding, 63.7% for exclusive breastfeeding to six months, and 45.9% for complementary feeding. Those are the conditions in which a “Top 5” reel travels: a legal advertising blackout on television, and a recommendation engine that still lets a creator rank tins by immunity and brain growth.

THE LAW’S WEIGHT AGAINST THE FEEDING NUMBERS

  • The jail term: An advertising or promotion breach under Section 20(1) of the 1992 Act can bring imprisonment of up to three years, or a fine of up to Rs 5,000, or both.
  • The feeding rates: NFHS-5 put exclusive breastfeeding to six months at 63.7% and complementary feeding at 45.9%.
  • The prior count: BPNI recorded 15 IMS Act violations in its 2022-23 monitoring window and warned that influencer mothers were already inside the ban.
  • The 2026 method: FSSAI is pairing that old criminal text with show-cause letters under the 2006 food-safety Act, which is how an unpaid reel becomes a company file.

Television spots for Stage 1 formula disappeared from Indian screens years ago because the 1992 Act made them a crime. The ranking reel is the format that filled the slot, and FSSAI has now treated it as the same act of promotion, with the creator and the named brands on one piece of paper. Abbott can still prove it never booked the post. The notice does not wait for that proof before it is issued.

Disclaimer: This article is news reporting on regulatory notices and company statements, and it is for information only. It is not medical advice on infant feeding, breastfeeding or the use of formula, and it is not legal advice on the Infant Milk Substitutes Act or the Food Safety and Standards Act. Readers making feeding decisions should consult a qualified paediatrician or other licensed health worker, and companies or creators facing a notice should consult a food-and-drug lawyer admitted in India. Product claims, case status and laboratory findings are those published by FSSAI and the named firms as of the dates cited, and they may change as replies are filed or orders are issued.

Harry is the editor of SOMALI UPDATE, an independent title he owns and runs. Ten years in journalism, from reporter to editor, have settled into a set of verification habits he applies to every story. A quote is checked against the recording or transcript it came from. A statement attributed to an organisation is confirmed on that organisation's own channels before it is repeated. A figure is traced to the dataset or filing that first published it, and a photograph is checked for when and where it was actually taken. If any of those checks fails, the claim is left out or clearly marked as unconfirmed. Those habits cover the whole site, which reports news, business, technology, science and sports along with entertainment, lifestyle, travel, auto and gaming for readers around the world. Product claims in the technology, auto and gaming pages are tested in use where Harry can get his hands on the product. Corrections are published under a public policy and noted on the article. Readers who want to question a fact can write to support@somaliupdate.com.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending